ReviewFrontiers in cardiovascular medicine2025
The effects of 5-HT on vascular endothelial dysfunction in patients with panic disorder.
Review in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sex-dependent modulation of CGRPergic neurovascular activity by 5-CT in rats.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Panic Disorder (PD) is a prevalent psychiatric condition characterized by recurrent episodes of acute severe anxiety. These episodes frequently present with symptoms that overlap with those of cardiovascular diseases (CVD), such as elevated blood pressure and chest pain. Despite the prevalence and impact of this comorbidity, the underlying mechanisms are not well understood and remain underexplored. This review synthesizes current understanding and recent findings on the role of 5-hydroxytryptamine (5-HT) in the intersection of PD and vascular dysfunction. 5-HT, a critical inhibitory neurotransmitter, has been implicated in the etiology of PD and linked to panic symptoms. This review underscores the importance of 5-HT in modulating vascular tone through its action on 5-HT1B and 5-HT2A receptors, influencing the production of nitric oxide (NO) and the subsequent vasomotor response. Furthermore, the impact of 5-HT system on platelet activation and aggregation adds another layer to the complex relationship between PD and CVD. Selective serotonin reuptake inhibitors (SSRIs) have shown promise in improving vascular endothelial function. However, the influence of SSRIs on CVD outcomes remains a controversial issue with conflicting findings from various studies. The review also highlights the role of the PI3K/Akt/eNOS signaling pathway in 5-HT's influence on vascular endothelial function. In conclusion, the intricate relationship between PD, 5-HT, and vascular endothelial function warrants further investigation. A deeper understanding of these mechanisms could lead to more effective treatments for PD and related CVD, ultimately improving patients' mental health and cardiovascular outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.